Abstract
Aim: The result of investigation on the procedure of sample handling and bioanalysis of small volume of plasma sample for nonclinical studies stored in 0.5-ml micronic tubes was reported. Results/methodology: Sample integrity of the small volume (25 μl) during long-term storage and the feasibility and data reliability of performing multiple re-assays on the small volume sample using 5 μl aliquot per analysis was evaluated. Conclusion: Integrity was maintained in samples (25 μl) stored for up to 1 month in 0.5-ml micronic tubes at -20°C. A 25 μl sample is sufficient for four-times of re-assays. This evaluation demonstrated the feasibility of this workflow of handling and bioanalysis on small volume plasma sample for GLP studies under the US FDA guidance.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 Overcoming the barriers to the uptake of nonclinical microsampling in regulatory safety studies. Drug Discov. Today 19 (5), 528–532 (2014). •• Review on the discussions at the workshop, current practice in the industry, regulatory experiences and the future direction of microsampling across drug development.
- 2 Capillary microsampling of 25 microl blood for the determination of toxicokinetic parameters in regulatory studies in animals. Bioanalysis 4 (6), 661–674 (2012).
- 3 Perforated dried blood spots: a novel format for accurate microsampling. Bioanalysis 3(20), 2321–2333 (2011).
- 4 A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit. Bioanalysis 7(6), 653–659 (2015). • Initial evaluation of volumetric absorbtive microsampler by multiple companies.
- 5 . LC-MS/MS and volumetric absorptive microsampling for quantitative bioanalysis of cathinone analogues in dried urine, plasma and oral fluid samples. J. Pharm. Biomed. Anal. 123(10), 186–194 (2016).
- 6 . Does volumetric absorptive microsampling eliminate the hematocrit bias for caffeine and paraxanthine in dried blood samples? A comparative study. Anal. Chim. Acta 881(30), 65–73 (2015). • Comparision study between volumetric absorbtive microsampler and dried blood spot on the eliminate of hematocrit bias.
- 7 A novel approach to capillary plasma microsampling for quantitative bioanalysis. Bioanalysis 5(9), 1131–1135 (2013).
- 8 . Capillary microsampling in the regulatory environment: validation and use of bioanalytical capillary microsampling methods. Bioanalysis 5(6), 731–738 (2013). •• Review on the use of capillary microsampling of plasma and blood for quantitation of drug exposure in animal studies.
- 9 Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes. Bioanalysis 6(3), 293–306 (2014).
- 10 The application of capillary microsampling in GLP toxicology studies. Bioanalysis 9(7), 531–540 (2017). •• Implentation of capillary microsampling in Good Laboratory Practice regulatory studies.
- 11 The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood. Rapid Commun. Mass Spectrom. 26(10), 1208–1212 (2012).
- 12 Simple, miniaturized blood plasma extraction method. Anal. Chem. 85(23), 11501–11508 (2013). • A rapid plasma extraction technology that collects a 2.5 μl aliquot of plasma within 3 min from a finger-stick derived drop of blood.
